Bio-Rad Laboratories Share Holder Equity 2010-2024 | BIO
Bio-Rad Laboratories share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Bio-Rad Laboratories share holder equity for the quarter ending December 31, 2024 was $6.569B, a 24.85% decline year-over-year.
- Bio-Rad Laboratories share holder equity for 2024 was $6.569B, a 24.85% decline from 2023.
- Bio-Rad Laboratories share holder equity for 2023 was $8.741B, a 9.09% decline from 2022.
- Bio-Rad Laboratories share holder equity for 2022 was $9.615B, a 29.74% decline from 2021.
| Bio-Rad Laboratories Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $6,569 |
| 2023 | $8,741 |
| 2022 | $9,615 |
| 2021 | $13,685 |
| 2020 | $9,880 |
| 2019 | $5,755 |
| 2018 | $4,020 |
| 2017 | $2,930 |
| 2016 | $2,579 |
| 2015 | $2,491 |
| 2014 | $2,185 |
| 2013 | $2,187 |
| 2012 | $2,016 |
| 2011 | $1,744 |
| 2010 | $1,541 |
| 2009 | $1,279 |
| Bio-Rad Laboratories Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $6,569 |
| 2024-09-30 | $7,488 |
| 2024-06-30 | $6,779 |
| 2024-03-31 | $9,051 |
| 2023-12-31 | $8,741 |
| 2023-09-30 | $8,416 |
| 2023-06-30 | $8,447 |
| 2023-03-31 | $9,764 |
| 2022-12-31 | $9,615 |
| 2022-09-30 | $8,454 |
| 2022-06-30 | $8,923 |
| 2022-03-31 | $10,183 |
| 2021-12-31 | $13,685 |
| 2021-09-30 | $15,332 |
| 2021-06-30 | $11,595 |
| 2021-03-31 | $10,609 |
| 2020-12-31 | $9,880 |
| 2020-09-30 | $8,825 |
| 2020-06-30 | $7,353 |
| 2020-03-31 | $6,293 |
| 2019-12-31 | $5,755 |
| 2019-09-30 | $5,131 |
| 2019-06-30 | $5,487 |
| 2019-03-31 | $4,864 |
| 2018-12-31 | $4,020 |
| 2018-09-30 | $4,900 |
| 2018-06-30 | $4,639 |
| 2018-03-31 | $4,488 |
| 2017-12-31 | $2,930 |
| 2017-09-30 | $2,848 |
| 2017-06-30 | $2,811 |
| 2017-03-31 | $2,707 |
| 2016-12-31 | $2,579 |
| 2016-09-30 | $2,703 |
| 2016-06-30 | $2,615 |
| 2016-03-31 | $2,544 |
| 2015-12-31 | $2,491 |
| 2015-09-30 | $2,430 |
| 2015-06-30 | $2,359 |
| 2015-03-31 | $2,199 |
| 2014-12-31 | $2,185 |
| 2014-09-30 | $2,177 |
| 2014-06-30 | $2,250 |
| 2014-03-31 | $2,233 |
| 2013-12-31 | $2,187 |
| 2013-09-30 | $2,124 |
| 2013-06-30 | $2,071 |
| 2013-03-31 | $2,031 |
| 2012-12-31 | $2,016 |
| 2012-09-30 | $1,935 |
| 2012-06-30 | $1,852 |
| 2012-03-31 | $1,840 |
| 2011-12-31 | $1,744 |
| 2011-09-30 | $1,694 |
| 2011-06-30 | $1,726 |
| 2011-03-31 | $1,613 |
| 2010-12-31 | $1,541 |
| 2010-09-30 | $1,428 |
| 2010-06-30 | $1,303 |
| 2010-03-31 | $1,301 |
| 2009-12-31 | $1,279 |
| 2009-09-30 | $1,228 |
| 2009-06-30 | $1,128 |
| 2009-03-31 | $1,058 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.672B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |